Infusion of an IL-10R-blocking antibody at day 60 elevated microglial activation markers and accelerated ALS onset, but viral vector-mediated overexpression of IL-10 in microglial cells dramatically delayed disease onset and increased the survival of SOD1G93A mice. Here, IL10 is linked to amyotrophic lateral sclerosis.